These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30468532)

  • 41. Mycological Considerations in the Topical Treatment of Superficial Fungal Infections.
    Rosen T
    J Drugs Dermatol; 2016 Feb; 15(2 Suppl):s49-55. PubMed ID: 26885799
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical and histological aspects of toenail onychomycosis caused by Aspergillus spp.: 34 cases treated with weekly intermittent terbinafine.
    Gianni C; Romano C
    Dermatology; 2004; 209(2):104-10. PubMed ID: 15316163
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Optimal management of fungal infections of the skin, hair, and nails.
    Gupta AK; Cooper EA; Ryder JE; Nicol KA; Chow M; Chaudhry MM
    Am J Clin Dermatol; 2004; 5(4):225-37. PubMed ID: 15301570
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mycology - an update Part 3: Dermatomycoses: topical and systemic therapy.
    Nenoff P; Krüger C; Paasch U; Ginter-Hanselmayer G
    J Dtsch Dermatol Ges; 2015 May; 13(5):387-410; quiz 411. PubMed ID: 25918080
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Fungal infections in primary care].
    Schaffner A
    Praxis (Bern 1994); 1996 Oct; 85(40):1236-9. PubMed ID: 8966412
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral itraconazole therapy for superficial, subcutaneous, and systemic infections. A panoramic view.
    De Rosso JQ; Gupta AK
    Postgrad Med; 1999 Jul; Spec No():46-52. PubMed ID: 10492666
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mycology - an update part 2: dermatomycoses: clinical picture and diagnostics.
    Nenoff P; Krüger C; Schaller J; Ginter-Hanselmayer G; Schulte-Beerbühl R; Tietz HJ
    J Dtsch Dermatol Ges; 2014 Sep; 12(9):749-77. PubMed ID: 25176455
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of oral antifungal agents for the treatment of superficial fungal infections in immunocompromised patients.
    Millikan LE
    Cutis; 2001 Jul; 68(1 Suppl):6-14. PubMed ID: 11499333
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Onychomycosis in Tehran, Iran: prevailing fungi and treatment with itraconazole.
    Khosravi AR; Mansouri P
    Mycopathologia; 2001; 150(1):9-13. PubMed ID: 11392568
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of mycoses in daily practice.
    Drago L; Micali G; Papini M; Piraccini BM; Veraldi S
    G Ital Dermatol Venereol; 2017 Dec; 152(6):642-650. PubMed ID: 29050446
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epidemiology and fungal species distribution of superficial mycoses in Northeast Brazil.
    Silva-Rocha WP; de Azevedo MF; Chaves GM
    J Mycol Med; 2017 Mar; 27(1):57-64. PubMed ID: 27663203
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dermatophyte test medium culture for evaluating toenail infections in patients with diabetes.
    Rich P; Harkless LB; Atillasoy ES
    Diabetes Care; 2003 May; 26(5):1480-4. PubMed ID: 12716808
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Improving Cure Rates in Onychomycosis.
    Gupta AK; Cernea M; Foley KA
    J Cutan Med Surg; 2016 Nov; 20(6):517-531. PubMed ID: 27313230
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Forty-eight-hour diagnosis of onychomycosis with subtyping of Trichophyton rubrum strains.
    Kardjeva V; Summerbell R; Kantardjiev T; Devliotou-Panagiotidou D; Sotiriou E; Gräser Y
    J Clin Microbiol; 2006 Apr; 44(4):1419-27. PubMed ID: 16597871
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Onychomycosis: a proposed revision of the clinical classification.
    Hay RJ; Baran R
    J Am Acad Dermatol; 2011 Dec; 65(6):1219-27. PubMed ID: 21501889
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Onychomycosis: Diagnosis and management.
    Singal A; Khanna D
    Indian J Dermatol Venereol Leprol; 2011; 77(6):659-72. PubMed ID: 22016272
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular diagnosis of onychomycosis.
    Petinataud D; Berger S; Contet-Audonneau N; Machouart M
    J Mycol Med; 2014 Dec; 24(4):287-95. PubMed ID: 25458365
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cutaneous malasseziasis: four case reports of atypical dermatitis and onychomycosis caused by Malassezia.
    Zhao Y; Li L; Wang JJ; Kang KF; Zhang QQ
    Int J Dermatol; 2010 Feb; 49(2):141-5. PubMed ID: 20465637
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A rationale for systemic treatment in onychomycosis with negative results on fungal examination.
    Amichai B; Davidovici B; Trau H; Lyakhovitsky A; Grunwald MH; Shemer A
    Clin Exp Dermatol; 2011 Oct; 36(7):724-7. PubMed ID: 21623878
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Superficial fungal infections in children.
    Hawkins DM; Smidt AC
    Pediatr Clin North Am; 2014 Apr; 61(2):443-55. PubMed ID: 24636655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.